Therapy with amlodipine besylate/benazepril HCl provides superior control in patients with severe systolic hypertension.

被引：0
|
作者：
Nwose, O [1 ]
Jean-Louis, L [1 ]
Schofield, L [1 ]
Purkayastha, D [1 ]
Baron, M [1 ]
机构：
[1] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
84
引用
收藏
页码：1034 / 1034
页数：1
相关论文
共 50 条
  • [41] Telmisartan in combination with amlodipine provides an effective treatment option for patients with moderate-or-severe hypertension: Sub-analysis from a factorial design study
    Littlejohn, T.
    Maju, C.
    Oigman, W.
    Olvera, R.
    Seeber, M.
    Guthrie, R.
    Singh, A.
    Koval, S.
    Kobe, M.
    JOURNAL OF HYPERTENSION, 2008, 26 : S460 - S461
  • [42] REDUCED ECG-LVH DURING ANTIHYPERTENSIVE THERAPY IS ASSOCIATED WITH LESS HOSPITALIZATION FOR HEART FAILURE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION. THE LIFE STUDY
    Larstorp, A.
    Olsen, M. H.
    Okin, P. M.
    Devereux, R. B.
    Ibsen, H.
    Dahloef, B.
    Kjeldsen, S. E.
    Wachtell, K.
    JOURNAL OF HYPERTENSION, 2010, 28 : E1 - E1
  • [43] EFFECT OF AGE, GENDER, RACE AND ETHNICITY ON EFFICACY OF AMLODIPINE/VALSARTAN/HYDROCHLOROTHIAZIDE TRIPLE COMBINATION THERAPY IN PATIENTS WITH MODERATE TO SEVERE HYPERTENSION
    Calhoun, D.
    Glazer, R.
    Yen, J.
    Lacourciere, Y.
    JOURNAL OF HYPERTENSION, 2009, 27 : S119 - S119
  • [44] Olmesartan medoxomil (OLM) plus amlodipine (AML) provides BP reduction and improves BP goal rate attainment in patients (pts) with moderate-to-severe hypertension
    Barrios, V.
    Laies, P.
    Ammentorp, B.
    Haag, U.
    Calderon, A.
    Escobar, C.
    JOURNAL OF HYPERTENSION, 2008, 26 : S472 - S473
  • [45] Triple Therapy With Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide in Adult Patients With Hypertension: The TRINITY Multicenter, Randomized, Double-Blind, 12-Week, Parallel-Group Study
    Oparil, Suzanne
    Melino, Michael
    Lee, James
    Fernandez, Victor
    Heyrman, Reinilde
    CLINICAL THERAPEUTICS, 2010, 32 (07) : 1252 - 1269
  • [46] An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in Chinese patients with mild to moderate hypertension
    Ueng, Kwo-Chang
    Lin, Lung-Chun
    Voon, Wen-Chol
    Lin, Ming-Cheng
    Liu, Yen-Bin
    Su, Ho-Ming
    Chang, Po-Yuan
    Lin, Tsung-Hsien
    Chen, Wei-Liang
    Wu, Chau-Chung
    Lai, Wen-Ter
    Lin, Chung-Sheng
    BLOOD PRESSURE, 2008, 17 : 24 - 31
  • [47] Blood pressure (BP)-lowering efficacy of olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) vs benazepril (BN) plus amlodipine (AML) therapy in black patients (pts) with stage 2 hypertension (HT)
    Neutel, J.
    Punzi, H.
    Xu, J.
    Lipka, L.
    Chavanu, K.
    Dubiel, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S455 - S455
  • [48] LCZ696, an Angiotensin Receptor Neprilysin Inhibitor, Provides Superior 24-hour Blood Pressure Reduction than Olmesartan in Japanese Patients with Systolic Hypertension
    Kario, Kazuomi
    Rakugi, Hiromi
    Yamaguchi, Masako
    Okino, Naoko
    Gotou, Hiromi
    Zhang, Jack
    CIRCULATION, 2014, 130
  • [49] A randomized, double-blind, placebo-controlled. factorial study evaluating the efficacy and safety of co-administration of amlodipine besylate plus olmesartan medoxomil compared to monotherapy in patients with mild to severe hypertension
    Chrysant, S. G.
    Melino, M.
    Karki, S.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S376 - S376
  • [50] Combination of valsartan/amlodipine is more effective than bisoprolol/hydrochlorothiazide on reduction of blood pressure variability in patients with moderate or severe hypertension after control
    Taha, N.
    Shehata, S.
    Abu-Zied, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 358 - 358
12345